Dr. Oxana Iliach has more than 15 years of experience in the healthcare industry including the last 10+ years in regulatory affairs. ​She has expertise in developing and executing regulatory strategies for drugs for rare diseases, pediatrics, and biosimilars, with a focus on Chemistry, Manufacturing and Control (CMC). Oxana’s specialty is biologics and cell and gene therapy products. Oxana has experience with the FDA, EMA, Health Canada, and other smaller agencies. ​She has a MSc in Chemistry and PhD in Pharmaceutical Science. ​Oxana Iliach is a member of Canadian Organization for Rare Disorders (CORD).